NDC Package 62135-501-30 Ultramicrosize Griseofulvin

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
62135-501-30
Package Description:
30 TABLET in 1 BOTTLE
Product Code:
Proprietary Name:
Ultramicrosize Griseofulvin
Non-Proprietary Name:
Ultramicrosize Griseofulvin
Substance Name:
Griseofulvin
Usage Information:
Ultramicrosize griseofulvin tablets are indicated for the treatment of ringworm infections of the skin, hair, and nails, namely: tinea corporis, tinea pedis, tinea cruris, tinea barbae, tinea capitis, tinea unguium (onychomycosis) when caused by one or more of the following genera of fungi: Trichophyton rubrum, Trichophyton tonsurans, Trichophyton mentagrophytes, Trichophyton interdigitale, Trichophyton verrucosum, Trichophyton megninii, Trichophyton gallinae,  Trichophyton crateriforme, Trichophyton sulphureum, Trichophyton schoenieinii, Microsporum audouini, Microsporum canis, Microsporum gypseum, and Epidermophyton floccosum.Note: Prior to therapy, the type of fungi responsible for the infection should be identified.The use of this drug is not justified in minor or trivial infections which will respond to topical agents alone.Griseofulvin is not effective in the following: bacterial infections, candidiasis (moniliasis), histoplasmosis, actinomycosis, sporotrichosis, chromoblastomycosis, coccidioidomycosis, North American blastomycosis, cryptococcosis (torulosis), tinea versicolor, and nocardiosis.
11-Digit NDC Billing Format:
62135050130
NDC to RxNorm Crosswalk:
RxCUI: 245248 - griseofulvin 165 MG Oral Tablet
Product Type:
Human Prescription Drug
Labeler Name:
Chartwell Rx, Llc
Dosage Form:
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
Sample Package:
No
FDA Application Number:
ANDA061996
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
04-06-1982
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 62135-501-30?

The NDC Packaged Code 62135-501-30 is assigned to a package of 30 tablet in 1 bottle of Ultramicrosize Griseofulvin, a human prescription drug labeled by Chartwell Rx, Llc. The product's dosage form is tablet and is administered via oral form.

Is NDC 62135-501 included in the NDC Directory?

Yes, Ultramicrosize Griseofulvin with product code 62135-501 is active and included in the NDC Directory. The product was first marketed by Chartwell Rx, Llc on April 06, 1982 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 62135-501-30?

The 11-digit format is 62135050130. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-262135-501-305-4-262135-0501-30